Cholesteryl Hemisuccinate CAS 1510-21-0: Advanced Lipid for Targeted Drug Delivery

Discover Cholesteryl Hemisuccinate (CAS 1510-21-0), a premium cholesterol derivative expertly synthesized by our facility. As a leading manufacturer and supplier in China, we provide this pH-sensitive lipid essential for innovative drug delivery systems like liposomes and nanoparticles, enhancing drug loading and stability for precise therapeutic outcomes. Inquire for competitive pricing and bulk orders.

Get a Quote & Sample

Why Choose Our Cholesteryl Hemisuccinate?

Exceptional Purity and Quality

Our Cholesteryl Hemisuccinate (CAS 1510-21-0) is manufactured to exacting standards, ensuring high purity for reliable performance in demanding pharmaceutical and research applications. Partner with a leading China manufacturer for consistent quality.

Reliable Supply Chain & Competitive Pricing

We offer a stable and dependable supply of Cholesteryl Hemisuccinate, ensuring your research and production timelines are met. As a direct manufacturer, we provide competitive pricing for bulk purchases, making advanced materials accessible.

Expert Support for Your Formulation Needs

Leverage our expertise as a specialized supplier. We can provide technical insights and support to help you effectively integrate Cholesteryl Hemisuccinate into your novel drug delivery systems and formulations.

Key Applications for Cholesteryl Hemisuccinate

Liposome Formulation

Essential for creating stable and pH-responsive liposomes, improving drug encapsulation efficiency and release profiles in pharmaceutical applications.

Nanoparticle Development

Utilized in the development of advanced nanoparticles for targeted drug delivery, leveraging its pH-sensitive nature for controlled release mechanisms.

Controlled Drug Release

A key component in systems designed for controlled release, adapting its charge and structure based on pH changes in the biological environment.

Enhancing Drug Stability

This lipid derivative plays a crucial role in protecting and stabilizing active pharmaceutical ingredients (APIs) within complex delivery vehicles.